Kooperationen / Fusionen

GBA Group expands range of consulting services for the medical device and pharmaceutical industry

With the acquisition of the Swedish company Key2Compliance AB (Key2Compliance), GBA Group is expanding its range of consulting and training services for the medical device, In Vitro Diagnostics (IVD), and pharmaceutical industry. GBA Group is thus taking another important step towards establishing itself as a broad service provider for international customers in this area.

Key2Compliance was founded in Stockholm, Sweden in 1994 and is one of the fastest-growing consultancy and training service provider for medical devices, IVD, and pharmaceuticals companies in the Scandinavian market. Key areas of expertise at Key2Compliance include Quality Assurance, Regulatory Affairs, Clinical Development (CRO), Biological Safety, as well as Training and Courses. Today, the company employs more than 70 experts and, in addition to its headquarters in Stockholm, has two other branches in Sweden and one in Copenhagen, Denmark.

Steffen Walter, CEO GBA Group explains, “As we have set ourselves the goal of being a broad-based service provider for medical devices, Key2Compliance, with its consulting and training services and expertise, is a perfect fit for GBA Group. The expansion of our service portfolio enables us to provide our customers with optimal support along the value chain, from preclinical development and the conduct of clinical trials through to production release and quality assurance”.

Jan Hellqvist, CEO Key2Compliance says, “With GBA Group, its structure and management we found the right partner to foster our ongoing journey of growth and internationalization. The company’s culture of entrepreneurship, local autonomy, and genuine support as well as the broad variety of revealing synergies between both companies’ services convinced me. Therefore, I believe that this step will significantly boost Key2Compliance and GBA Group, and I‘m eagerly anticipating the years to come.”

Über GBA GROUP

GBA Group is an international life science services company with over 2,500 employees in 11 countries and a wide range of analytical, logistical and specialist services in the fields of pharmaceuticals, medical devices, cosmetics, chemicals, food, drinking water and the environment. The group stands for outstanding technical expertise, efficient processes and focus on customer benefits with regard to its activities in the fields of research, product development, market development and consumer protection. With its services, GBA Group directly and indirectly makes a sustainable contribution to health, the environment and society.

Firmenkontakt und Herausgeber der Meldung:

GBA GROUP
Goldtschmidtstraße 5
21073 Hamburg
Telefon: +49 (40) 797172-0
Telefax: +49 (40) 797172-27
https://www.gba-group.com

Ansprechpartner:
Sabine Nest
Head of Corporate Communication
E-Mail: presse@gba-group.de
Für die oben stehende Story ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel